As of June 18, 2025, Dantax A/S has a Discounted Cash Flow (DCF) derived fair value of $21.06 per share. With the current market price at $505.00, this represents a potential upside of -95.8%.
Key Metrics | Value |
---|---|
DCF Fair Value (5-year) | $0.58 |
DCF Fair Value (10-year) | $21.06 |
Potential Upside (5-year) | -99.9% |
Potential Upside (10-year) | -95.8% |
Discount Rate (WACC) | 5.2% - 7.0% |
Revenue is projected to grow from $27 million in 06-2024 to $32 million by 06-2034, representing a compound annual growth rate of approximately 1.7%.
Fiscal Year | Revenue (USD millions) | Growth |
---|---|---|
06-2024 | 27 | 22% |
06-2025 | 24 | -11% |
06-2026 | 24 | 2% |
06-2027 | 25 | 2% |
06-2028 | 26 | 4% |
06-2029 | 27 | 5% |
06-2030 | 28 | 2% |
06-2031 | 29 | 4% |
06-2032 | 30 | 3% |
06-2033 | 31 | 4% |
06-2034 | 32 | 4% |
Net profit margin is expected to improve from 49% in 06-2024 to 59% by 06-2034, driven by operational efficiency and economies of scale.
Fiscal Year | Net Profit (USD millions) | Profit Margin |
---|---|---|
06-2024 | 13 | 49% |
06-2025 | 12 | 51% |
06-2026 | 13 | 53% |
06-2027 | 14 | 54% |
06-2028 | 15 | 56% |
06-2029 | 16 | 58% |
06-2030 | 16 | 58% |
06-2031 | 17 | 58% |
06-2032 | 18 | 59% |
06-2033 | 18 | 59% |
06-2034 | 19 | 59% |
with a 5-year average of $0 million. Projected CapEx is expected to maintain at approximately 0% of revenue.
Depreciation is based on an average useful life of 5 years for capital assets.
Fiscal Year | D&A (USD millions) |
---|---|
06-2025 | 0 |
06-2026 | 0 |
06-2027 | 0 |
06-2028 | 0 |
06-2029 | 0 |
06-2030 | 0 |
Net working capital is expected to increase gradually, with projected changes affecting free cash flow.
Components | Average Days |
---|---|
Days Receivables | 33 |
Days Inventory | 345 |
Days Payables | 15 |
Fiscal Year | EBITDA | Tax | CapEx | Change in NWC | FCF |
---|---|---|---|---|---|
3M/2025 | 0 | 1 | 0 | 0 | (1) |
2026 | 3 | 4 | 0 | (0) | (1) |
2027 | 3 | 4 | 0 | (1) | 1 |
2028 | 4 | 4 | 0 | 1 | (1) |
2029 | 5 | 4 | 0 | (0) | 0 |
Valuation Method | Fair Price (USD) | Potential Upside |
---|---|---|
5-Year DCF (Growth) | 0.58 | -99.9% |
10-Year DCF (Growth) | 21.06 | -95.8% |
5-Year DCF (EBITDA) | 47.21 | -90.7% |
10-Year DCF (EBITDA) | 55.79 | -89.0% |
Is Dantax A/S (DANT.CO) a buy or a sell? Dantax A/S is definitely a sell. Based on our DCF analysis, Dantax A/S (DANT.CO) appears to be overvalued with upside potential of -95.8%. The company's strong projected growth in revenue and profitability, coupled with consistent capital expenditure, supports our positive outlook on its intrinsic value.
Key investment drivers include:
Investors should consider reducing exposure at the current market price of $505.00.